DCM
SLRN

DAFNA Capital Management’s ACELYRIN SLRN Stock Holding History

DAFNA Capital Management’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-87,989
Closed -$276K – 89
2024
Q4 		$276K Sell
87,989
-514,905
-85% -$2.49M 0.07% 79
2024
Q3 		$2.97M Sell
602,894
-90,715
-13% -$468K 0.7% 35
2024
Q2 		$3.06M Buy
693,609
+491,022
+242% +$2.3M 0.73% 35
2024
Q1 		$1.37M Sell
202,587
-168,613
-45% -$1.28M 0.31% 56
2023
Q4 		$2.77M Buy
371,200
+363,900
+4,985% +$3.11M 0.66% 38
2023
Q3 		$74.2K Buy
+7,300
New +$155K 0.02% 75

Other funds holding SLRN

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $426M AUM 838% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

DAFNA Capital Management's SLRN Position: Q1 2025 in Review

DAFNA Capital Management sold out of ACELYRIN (SLRN) in Q1 2025, closing a stake of 87,989 shares — an estimated $276K sold.

DAFNA Capital Management first reported a position in SLRN in Q3 2023 and held it in 6 quarters. The position peaked at $3.06M in Q2 2024. 105 funds tracked by Wall St. Rank hold SLRN as of Q1 2025.

  • DAFNA Capital Management reported no remaining ACELYRIN position as of Q1 2025 after selling out during the quarter.
  • DAFNA Capital Management sold 87,989 ACELYRIN shares in Q1 2025, an estimated $276K.
  • DAFNA Capital Management first reported a position in ACELYRIN in Q3 2023 and held it in 6 quarters.
  • DAFNA Capital Management's ACELYRIN position peaked at $3.06M in Q2 2024.
  • 105 funds tracked by Wall St. Rank held ACELYRIN as of Q1 2025.

Based on DAFNA Capital Management's 13F filing for Q1 2025, filed 15 May 2025.